← SynDRA
USL-311
SynDRA canonical compound SYN0039598 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | CXCR4 |
|---|
| Mechanism of action | cc chemokine receptor antagonist |
|---|
| Indication | glioblastoma |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- cc chemokine receptor antagonist
- CXCR4 ANTAGONIST
Cross-references
Synonyms
- USL311
- UNII-2BTG5MX2Q2
- 2BTG5MX2Q2
- SCHEMBL15347153
- 2-Pyridinecarboxamide, 6-(hexahydro-4-(1-(1-methylethyl)-4-piperidinyl)-1H-1,4-diazepin-1-yl)-N-4-pyridinyl-
- RefChem:193366
- CXCR4 Inhibitor USL311
- CXCR4 ANTAGONIST USL311
- orb1307630
- SCHEMBL29374319
- USL 311 [WHO-DD]
- C24H34N6O
- EX-A5298
- USL-311?
- AKOS037648701
- NCGC00689309-01
- AC-36731
- BS-15271
- DA-58918
- HY-114244
- CS-0080568
- USL-311; USL 311; USL311
- D80829
- T17208
- EN300-22831076
Look up USL-311 in the interactive SynDRA portal →